In ovarian cancers, including HGSOC, the PI3K/AKT/mTOR pathway is frequently hyperactivated through various genetic alterations, driving cell proliferation, migration, and chemotherapy resistance [15,16]. The gene discussed is MTOR; the disease is ovarian cancer.